Fund HoldingsKrensavage Asset Management, LLC

Total Portfolio Value
$188.9K
Total Bought
$22.7K
Total Sold
$19.9K
Net Transaction
+$2.8K
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
JOHNSON & JOHNSON(JNJ)040,000+40,000063.23%+6
INDIVIOR PLC965,368974,474+9,1069147.60%+5
JAZZ PHARMACEUTICALS PLC(JAZZ)100,703164,816+64,11313179.26%+5
ENANTA PHARMACEUTICALS INC2,116,5862,114,444-2,14212168.46%+4
REGENERON PHARMACEUTICALS(REGN)04,000+4,000021.11%+2
VANDA PHARMACEUTICALS INC754,3811,024,883+270,502352.56%+1
AVADEL PHARMACEUTICALS950,000958,877+8,877784.49%+1
SUPERNUS PHARMACEUTICALS INC(SUPN)431,986472,376+40,39014157.88%+1
MURAL ONCOLOGY PLC70,2630-70,26300-0
GSK PLC-SPON ADR(GSK)272,000271,729-27111105.52%-0
BIONTECH SE-ADR(BNTX)87,56373,382-14,181884.14%-0
ALKERMES PLC(ALKS)207,822207,8220763.15%-1
SANOFI-ADR(SNY)149,096148,946-150873.81%-1
UNITED THERAPEUTICS CORP(UTHR)98,228101,146+2,918302915.38%-1
CARDINAL HEALTH INC(CAH)188,745133,745-55,000262211.89%-4
EXELIXIS INC(EXEL)878,533493,526-385,007322211.51%-11
Page 1 of 1